19-51491682-C-G

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_053003.4(SIGLEC12):​c.1747G>C​(p.Ala583Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000141 in 1,613,492 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A583S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

SIGLEC12
NM_053003.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.318

Publications

2 publications found
Variant links:
Genes affected
SIGLEC12 (HGNC:15482): (sialic acid binding Ig like lectin 12) Sialic acid-binding immunoglobulin-like lectins (SIGLECs) are a family of cell surface proteins belonging to the immunoglobulin superfamily. They mediate protein-carbohydrate interactions by selectively binding to different sialic acid moieties present on glycolipids and glycoproteins. This gene encodes a member of the SIGLEC3-like subfamily of SIGLECs. Members of this subfamily are characterized by an extracellular V-set immunoglobulin-like domain followed by two C2-set immunoglobulin-like domains, and the cytoplasmic tyrosine-based motifs ITIM and SLAM-like. The encoded protein, upon tyrosine phosphorylation, has been shown to recruit the Src homology 2 domain-containing protein-tyrosine phosphatases SHP1 and SHP2. It has been suggested that the protein is involved in the negative regulation of macrophage signaling by functioning as an inhibitory receptor. This gene is located in a cluster with other SIGLEC3-like genes on 19q13.4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.039429724).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SIGLEC12NM_053003.4 linkc.1747G>C p.Ala583Pro missense_variant Exon 8 of 8 ENST00000291707.8 NP_443729.1 Q96PQ1-1
SIGLEC12NM_033329.2 linkc.1393G>C p.Ala465Pro missense_variant Exon 7 of 7 NP_201586.1 Q96PQ1-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SIGLEC12ENST00000291707.8 linkc.1747G>C p.Ala583Pro missense_variant Exon 8 of 8 1 NM_053003.4 ENSP00000291707.3 Q96PQ1-1
SIGLEC12ENST00000596742.1 linkn.*962G>C non_coding_transcript_exon_variant Exon 8 of 8 1 ENSP00000469791.1 M0QYF3
SIGLEC12ENST00000596742.1 linkn.*962G>C 3_prime_UTR_variant Exon 8 of 8 1 ENSP00000469791.1 M0QYF3
SIGLEC12ENST00000598614.1 linkc.1393G>C p.Ala465Pro missense_variant Exon 7 of 7 5 ENSP00000472873.1 Q96PQ1-2

Frequencies

GnomAD3 genomes
AF:
0.0000924
AC:
14
AN:
151574
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000394
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000884
Gnomad OTH
AF:
0.000962
GnomAD2 exomes
AF:
0.000155
AC:
39
AN:
251404
AF XY:
0.000177
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000231
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.000229
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000146
AC:
213
AN:
1461800
Hom.:
0
Cov.:
31
AF XY:
0.000140
AC XY:
102
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33478
American (AMR)
AF:
0.000268
AC:
12
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.0000936
AC:
5
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.000160
AC:
178
AN:
1111958
Other (OTH)
AF:
0.000282
AC:
17
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000923
AC:
14
AN:
151692
Hom.:
0
Cov.:
31
AF XY:
0.0000809
AC XY:
6
AN XY:
74160
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41304
American (AMR)
AF:
0.000394
AC:
6
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4784
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000884
AC:
6
AN:
67850
Other (OTH)
AF:
0.000952
AC:
2
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000102
ExAC
AF:
0.000181
AC:
22
EpiCase
AF:
0.000109
EpiControl
AF:
0.000237

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 04, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1747G>C (p.A583P) alteration is located in exon 8 (coding exon 8) of the SIGLEC12 gene. This alteration results from a G to C substitution at nucleotide position 1747, causing the alanine (A) at amino acid position 583 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
6.8
DANN
Benign
0.96
DEOGEN2
Benign
0.0046
T;.
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.0079
N
LIST_S2
Benign
0.58
T;T
M_CAP
Benign
0.0015
T
MetaRNN
Benign
0.039
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.2
M;.
PhyloP100
-0.32
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.3
N;.
REVEL
Benign
0.15
Sift
Benign
0.16
T;.
Sift4G
Uncertain
0.033
D;T
Polyphen
0.056
B;B
Vest4
0.31
MVP
0.19
MPC
0.061
ClinPred
0.043
T
GERP RS
1.7
Varity_R
0.092
gMVP
0.067
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144791372; hg19: chr19-51994936; API